Chronic myeloid leukemia patients who develop grade I/II pleural effusion under second-line dasatinib have better responses and outcomes than patients without pleural effusion
| Autor: | Eskazan, Ahmet Emre, Eyice, Deniz, Kurt, Enes Ali, Elverdi, Tugrul, Yalniz, Fevzi Firat, Salihoglu, Ayse, Ar, Muhlis Cem, Ongoren Aydin, Seniz, Baslar, Zafer, Ferhanoglu, Burhan, Aydin, Yildiz, Tuzuner, Nukhet, Ozbek, Ugur, Soysal, Teoman |
|---|---|
| Zdroj: | In Leukemia Research July 2014 38(7):781-787 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect